A detailed history of American Portfolios Advisors transactions in Avita Medical, Inc. stock. As of the latest transaction made, American Portfolios Advisors holds 14 shares of RCEL stock, worth $180. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14
Holding current value
$180
% of portfolio
0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Mar 17, 2023

BUY
$4.97 - $7.89 $69 - $110
14 New
14 $74,000
Q4 2021

Mar 21, 2023

BUY
$11.72 - $19.66 $328 - $550
28 Added 200.0%
42 $503,000
Q3 2021

Mar 22, 2023

BUY
$16.73 - $20.9 $468 - $585
28 Added 200.0%
42 $744,000
Q2 2021

Mar 22, 2023

BUY
$17.23 - $22.02 $482 - $616
28 Added 200.0%
42 $862,000
Q1 2021

Mar 22, 2023

BUY
$18.38 - $28.41 $514 - $795
28 Added 200.0%
42 $832,000
Q4 2020

Mar 22, 2023

BUY
$17.55 - $27.2 $491 - $761
28 Added 200.0%
42 $780,000
Q3 2020

Mar 22, 2023

BUY
$20.83 - $30.0 $583 - $840
28 Added 200.0%
42 $1.06 Million
Q2 2020

Mar 24, 2023

BUY
$26.1 - $34.6 $730 - $968
28 Added 200.0%
42 $1.28 Million

Others Institutions Holding RCEL

About AVITA Medical, Inc.


  • Ticker RCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 25,030,900
  • Market Cap $322M
  • Description
  • AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and prop...
More about RCEL
Track This Portfolio

Track American Portfolios Advisors Portfolio

Follow American Portfolios Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.